Longevity Leaders World Congress Transparent 140x
Executive Forums

You might qualify for an invitation-only Executive Forum

Executive Forums are a staple and firm favourite at our events. These are an invitation only exclusive boardroom forums where all participants are active discussants and have an equal voice.

Limited to a maximum of 30 participants to ensure conversation is meaningful, they follow a strict Chatham House Rule policy and includes peer review of several case studies and a general discussion focused.

Take advice from your peers in a non-competitive setting

Connect with other like-minded executives

Set a strategic agenda for leaders in your industry


Pensions Forum: Scheme funding vs risk management
For corporate pension sponsors and trustees only

Case studies:
John Chilman, CEO, RPMI
Joel Griffin, Head of Global Pensions and Benefits, Rolls Royce

Nadeem Ladha, Trustee Director, 202-20 Trustees
Holly Copley, Head of Consulting, BA Pension Trustees
Andrew Cole, Trustee, BESTrustees
Paul Rogers, Director, Pensions Risk, BT
Ellen Ratcliffe, Head of Group Pensions, Capita Plc
Rachel Graham, Trustee Director, Dalriada Trustees
Hugh Nolan, Trustee Director, Dalriada Trustees
Jonathan Clark, Trustee, Independent
Fiona Brown, Head of Group Pensions, Rolls Royce
John Smith, Head of Pensions, Siemens AG
John Williams, Head of Pensions, Syngenta

Biotech CEO Forum: Driving clinical translation of healthspan biotech
For biotech CxOs only

Case studies:
Tom Hughes, CEO, Navitor
Samuel Agus, CMO, Biophytis

Steven Braithwaite, Chief Scientific Officer, Alkahest
Eric Morgen, Chief Medical Officer and Chief Operating Officer, BioAge Labs
Judith Campisi, Professor of Biogerontology, Buck Institute for Research on Ageing
Peter de Keizer, Associate Professor, UMT Utrecht; and Scientific Founder, Cleara Biotech
S. Jay Olshansky, Co-Founder and Chief Science Officer, Lapetus Solutions, Inc
Reason, Co-Founder and Chief Executive Officer, Repair Biotechnologies
Marc Ramis Castelltort, Chief Executive Officer, Senolytic Therapeutics
Reenie McCarthy, CEO, Stealth Biotherapeutics

Business Leaders Forum: Capturing the value of an experienced workforce
For FTSE100 CxOs only

Case studies:
Maryon Stewart, Founder, Health Wise & Well
Debra Whitman,
Chief Public Policy Officer, AARP

Pat Milligan, Global Leaders, Multinational Client Group & When Women Thrive, Mercer

Tracy Garrard, CEO, AXA PPP
Lesley Johnson, Home Entertainment Director, BBC Studios
Cliff Prior, Chief Executive Officer, Big Society Capital
Uday Bose, Managing Director, Boerhinger Ingelheim
Richard Corbridge, Director of Innovation, Boots
Alice Hu Wagner, Managing Director, British Business Bank
Anna Dixon, Chief Executive, Centre for Ageing Better
Louise Ansari, Director of Communication, Centre for Ageing Better
Paula Broadbent, Retirement Solutions Director, Engie
Sally Greengross , Chief Executive, International Longevity Centre
John Godfrey, Corporate Affairs Director, Legal & General
Andrew Scott, Professor of Economics, London Business School
Lynda Gratton, Professor of Management Practice, London Business School
Clive Bolton, Head of Life & Pensions, LV=
Yvonne Sonsino, Partner & Innovation Leader, Mercer
Noel Gordon, Chair, NHS Digital
Simon Wainwright, Chief Executive Officer, RGA UK
Andrew Reynolds, Chief Executive & Global Board Director, RLB UK Ltd
Paul Murray, CEO, Swiss Re
Andy Briggs, CEO , The Phoenix Group
Jane Townson, CEO, UKHCA
Helen Lamprell, General Counsel & External Affairs Director, Vodafone

Places are strictly limited and by invitation-only. To find out if you qualify please email marketing@lsxleaders.com.